FDA全球物质注册数据库(FDA Global Substance Registration System)
检索条件:" RN=1931944-80-7"
物质名称 CAS登记号 物质唯一标识 分子式 异名/同义词
DONANEMAB 1931944-80-7 1ADB65P1KK 1ADB65P1KK DONANEMAB
DONANEMAB [INN]
DONANEMAB [USAN]
DONANEMAB [WHO-DD]
DONANEMAB AZBT [WHO-DD]
DONANEMAB-AZBT
IMMUNOGLOBULIN G1, ANTI-(HUMAN PYROGLUTAMYL A.BETA. (3-X) PEPTIDE)(HUMAN CLONE LY3002813 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN CLONE LY3002813 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS APP (AMYLOID BETA A4 PRECURSOR PROTEIN) A BETA 3-PYROGLUTAMYL PEPTIDES, A.BETA. 3 (3-X)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-444) (VH (HOMO SAPIENS IGHV1-3*01 (84.7%)-(IGHD)-IGHJ4*01 (91.7%)) (8.8.8) (1-115)-HOMO SAPIENS IGHG1*01 (100%) G1M17,1 (CH1 K120 (212) (116-213), HINGE (214-228), CH2 (229-338), CH3 D12 (354), L14 (356) (339-443), CHS K2>DEL (444)) (116-444)), (218-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV2-29*02 (89.0%)-IGKJ2*02 (100%)) (11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (158), V101 (196) (113'-219'))DIMER (224-224'':227-227'')-BISDISULFIDE
KISUNLA
LY 3002813
LY-3002813
英文物质名称,关联名称搜索 高级检索
©2006-2026 Drugfuture->FDA Global Substance Registration System